Bicara Therapeutics Statistics
NASDAQ: BCAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.44-0.68 (-7.46%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Bicara Therapeutics by the numbers
Bicara Therapeutics has a market capitalization of $560.3 million based on 66.39M shares outstanding. With trailing EPS of $-3.46, Bicara Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.3% below its 50-day average and 59.1% below its 200-day average.
Average daily trading volume is 1.20M shares, or about $10.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCAX valuation vs. peer median
| Metric | BCAX | Peer median | Difference |
|---|---|---|---|
| Market cap | $560.31M | $548.11M | +2% |
| Avg. volume | 1.20M | 1.37M | -12% |
Peer median across 8 companies: GERN, ANL, ACRS, AVBP, CBIO, DSGN, CLYM, IMMX.
Valuation
- Market cap
- $560.31M
- EPS (TTM)
- $-3.46
- Shares outstanding
- 66.39M
Price and trading
- Previous close
- 9.12
- Open
- 8.83
- Day range
- 8.43 – 9.14
- 52-week range
- 7.87 – 30.99
- 52-week change
- -53.22%
- Beta
- —
- Volume
- 814.49K
- Average volume
- 1.20M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 560.31M
- Forward Pe
- -2.15
- Eps
- -3.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 30.99
- Week52 Low
- 7.87
- Avg Volume
- 1.20M
- Shares Outstanding
- 66.39M
- Ma50
- 15.43
- Ma200
- 20.65
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -72.77%
- Pct From52w Low
- 7.24%